Imidazole antibiotics inhibit the nitric oxide dioxygenase function of microbial flavohemoglobin

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 5, 2005, Pages 1837-1843

  Helmick, Ryan A ^a   Fletcher, Arm E ^a   Gardner, Anne M ^a   Gessner, Christopher R ^a   Hvitved, Angela N ^b   Gustin, Michael C ^b   Gardner, Paul R ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b RICE UNIVERSITY   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; ECONAZOLE; FLAVOHEMOGLOBIN; HEMOGLOBIN; IMIDAZOLE; IRON; KETOCONAZOLE; METHEMOGLOBIN; MICONAZOLE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DIOXYGENASE; OXYGEN; OXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CELL KILLING; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; GROWTH INHIBITION; IMMUNOCOMPETENT CELL; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; WAUTERSIA EUTROPHA; YEAST;

ANTI-BACTERIAL AGENTS; CANDIDA ALBICANS; DIHYDROPTERIDINE REDUCTASE; ENZYME INHIBITORS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FLAVIN-ADENINE DINUCLEOTIDE; HEME; HEMEPROTEINS; IMIDAZOLES; KINETICS; NAD; NADH, NADPH OXIDOREDUCTASES; NITRIC OXIDE; OXIDATION-REDUCTION; OXYGENASES; PLASMIDS;

EID: 18244362036     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.5.1837-1843.2005     Document Type: Article

References (64)

1. Bammert, G. F., and J. M. Fostel. 2000. Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob. Agents Chemother. 44:1255-1265.
2. Bellamine, A., A. T. Mangla, W. D. Nes, and M. R. Waterman. 1999. Characterization and catalytic properties of the sterol 14α-demethylase from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 96:8937-8942.
3. Cornelissen, F., and H. Van den Bossche. 1983. Synergism of the antimicrobial agents miconazole, bactracin and polymyxin B. Chemotherapy 29:419-427.
4. Crawford, M. J., and D. E. Goldberg. 1998. Regulation of the Salmonella typhimurium flavohemoglobin gene. A new pathway for bacterial gene expression in response to nitric oxide. J. Biol. Chem. 273:34028-34032.
5. Dabbs, E. R., S. Naidoo, C. Lephoto, and N. Nikitina. 2003. Pathogenic Nocardia, Rhodococcus, and related organisms are highly susceptible to imidazole antifungals. Antimicrob. Agents Chemother. 47:1476-1478.
6. De Backer, M. D., T. Ilyina, X.-J. Ma, S. Vandoninck, W. H. M. L. Luyten, and H. Vanden Bossche. 2001. Genomic profiling of the response of Candida albicans to itraconazole treatment using DNA microarray. Antimicrob. Agents Chemother. 45:1660-1670.
7. de Jesús-Berrîos, M., L. Liu, J. C. Nussbaum, G. M. Cox, J. S. Stamler, and J. Heitman. 2003. Enzymes that counteract nitrosative stress promote fungal virulence. Curr. Biol. 13:1963-1968.
8. De Nollin, S., and M. Borgers. 1977. The effects of miconazole on the ultrastructure of Candida albicans. Proc. R. Soc. Med. 70:9-12.
9. De Nollin, S., H. Van Belle, F. Goossens, F. Thone, and M. Borgers. 1977. Cytochemical and biochemical studies of yeasts after in vitro exposure to miconazole. Antimicrob. Agents Chemother. 11:500-513.
10. Eriksson, S., S. Lucchini, A. Thompson, M. Rhen, and J. C. D. Hinton. 2003. Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol. Microbiol. 47:103-118.
11. Ermler, U., R. A. Siddiqui, R. Cramm, and B. Friedrich. 1995. Crystal structure of the flavohemoglobin from Alcaligenes eutrophus at 1.75Å resolution. EMBO J. 14:6067-6077.
12. Fang, F. C. 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2:820-832.
13. Favey, S., G. Labesse, V. Vouille, and M. Boccara. 1995. Flavohaemoglobin HmpX: a new pathogenicity determinant in Erwinia chrysanthemi strain 3937. Microbiology 141:863-871.
14. Firoved, A. M., and V. Deretic. 2003. Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa. J. Bacteriol. 185:1071-1081.
15. Frey, A. D., J. Farrés, C. J. T. Bollinger, and P. T. Kallio. 2002. Bacterial hemoglobins and flavohemoglobins for alleviation of nitrosative stress in Escherichia coli. Appl. Environ. Microbiol. 68:4835-4840.
16. Gardner, A. M., and P. R. Gardner. 2002. Flavohemoglobin detoxifies nitric oxide in aerobic, but not anaerobic, Escherichia coli: evidence for a novel inducible anaerobic nitric oxide scavenging activity. J. Biol. Chem. 277:8166-8171.
17. 54 in the nitric oxide stress response. J. Biol. Chem. 278:10081-10086.
18. Gardner, A. M., R. A. Helmick, and P. R. Gardner. 2002. Flavorubredoxin: an inducible catalyst for nitric oxide reduction and detoxification in Escherichia coli. J. Biol. Chem. 277:8172-8177.
19. Gardner, A. M., L. A. Martin, P. R. Gardner, Y. Dou, and J. S. Olson. 2000. Steady-state and transient kinetics of Escherichia coli nitric oxide dioxygenase (flavohemoglobin): the tyrosine B10 hydroxyl is essential for dioxygen binding and catalysis. J. Biol. Chem. 275:12581-12589.
20. Gardner, P. R. 2005. Nitric oxide dioxygenase function and mechanism of flavohemoglobin, hemoglobin, myoglobin and their associated reductases. J. Inorg. Biochem. 99:247-266.
21. Gardner, P. R., G. Costantino, and A. L. Salzman. 1998. Constitutive and adaptive detoxification of nitric oxide in Escherichia coli. Role of nitric oxide dioxygenase in the protection of aconitase. J. Biol. Chem. 273:26528-26533.
22. Gardner, P. R., G. Costantino, C. Szabó, and A. L. Salzman. 1997. Nitric oxide sensitivity of the aconitases. J. Biol. Chem. 272:25071-25076.
23. Gardner, P. R., A. M. Gardner, and C. K. Hallstrom. 2004. Dioxygen-dependent metabolism of nitric oxide, p. 133-150. In A. Hassid (ed.), Nitric oxide protocols, 2nd ed., vol. 279. Humana Press, Totowa, N.J.
24. Gardner, P. R., A. M. Gardner, L. A. Martin, Y. Dou, T. Li, J. S. Olson, H. Zhu, and A. F. Riggs. 2000. Nitric oxide dioxygenase activity and function of flavohemoglobins. Sensitivity to nitric oxide and carbon monoxide inhibition. J. Biol. Chem. 275:31581-31587.
25. Gardner, P. R., A. M. Gardner, L. A. Martin, and A. L. Salzman. 1998. Nitric oxide dioxygenase: an enzymic function for flavohemoglobin. Proc. Natl. Acad. Sci. USA 95:10378-10383.
26. Hausladen, A., A. J. Gow, and J. S. Stamler. 1998. Nitrosative stress: metabolic pathway involving the flavohemoglobin. Proc. Natl. Acad. Sci. USA 95:14100-14105.
27. Hibbs, J. B., Jr. 2002. Infection and nitric oxide. J. Infect. Dis. 185:S9-S17.
28. Ilari, A., A. Bonamore, A. Farina, K. A. Johnson, and A. Boffi. 2002. The X-ray structure of ferric Escherichia coli flavohemoglobin reveals an unexpected geometry of the distal heme pocket. J. Biol. Chem. 277:23725-23732.
29. Jones, B. M., I. Geary, M. E. Lee, and B. I. Duerden. 1989. Comparison of the in vitro activities of fenticonazole, other imidazoles, metronidazole, and tetracycline against organisms associated with bacterial vaginosis and skin infections. Antimicrob. Agents Chemother. 33:970-972.
30. Kerridge, D. 1986. Mode of action of clinically important antifungal drugs. Adv. Microb. Physiol. 27:1-72.
31. Liu, L., M. Zeng, A. Hausladen, J. Heitman, and J. S. Stamler. 2000. Protection from nitrosative stress by yeast flavohemoglobin. Proc. Natl. Acad. Sci. USA 97:4672-4676.
32. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
33. Marriott, M. S. 1980. Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals. J. Gen. Microbiol. 117:253-255.
34. McElhaney-Feser, G. E., R. E. Raulli, and R. L. Cihlar. 1998. Synergy of nitric oxide and azoles against Candida species in vitro. Antimicrob. Agents Chemother. 42:2342-2346.
35. McLean, K. J., M. R. Cheesman, S. L. Rivers, A. Richmond, D. Leys, S. K. Chapman, G. A. Reid, N. C. Price, S. M. Kelly, J. Clarkson, W. E. Smith, and A. W. Munro. 2002. Expression, purification and spectroscopic characterization of the P450 CYP121 from Mycobacterium tuberculosis. J. Inorg. Biochem. 91:527-541.
36. Membrillo-Hernández, J., M. D. Coopamah, M. F. Anjum, T. M. Stevanin, A. Kelly, M. N. Hughes, and R. K. Poole. 1999. The flavohemoglobin of Escherichia coli confers resistance to a nitrosating agent, a "nitric oxide releaser," and paraquat and is essential for transcriptional responses to oxidative stress. J. Biol. Chem. 274:748-754.
37. Moore, C. M., M. M. Nakano, T. Wang, R. W. Ye, and J. D. Helmann. 2004. Response of Bacillus subtilis to nitric oxide and the nitrosating agent sodium nitroprusside. J. Bacteriol. 186:4655-4664.
38. Mukhopadhyay, P., M. Zheng, L. A. Bedzyk, R. A. LaRossa, and G. Storz. 2004. Prominent roles of the NorR and Fur regulators in the Escherichia coli transcriptional response to reactive nitrogen species. Proc. Natl. Acad. Sci. USA 101:745-750.
39. Nakahara, K., T. Tanimoto, K.-I. Hatano, K. Usuda, and H. Shoun. 1993. Cytochrome P-450 55A1 (P-450dNIR) acts as nitric oxide reductase employing NADH as the direct electron donor. J. Biol. Chem. 268:8350-8355.
40. Nathan, C. 2004. Antibiotics at the crossroads. Are we making the right choices to bring new drugs to the marketplace? Nature 431:899-902.
41. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
42. Nicholas, R. O., and D. Kerridge. 1989. Correlation of inhibition of sterol synthesis with growth-inhibitory action of imidazole antimycotics in Candida albicans. J. Antimicrob. Chemother. 23:7-19.
43. Nozaki, Y. 1986. Determination of the concentration of protein by dry weight-a comparison with spectrophotometric methods. Arch. Biochem. Biophys. 249:437-446.
44. Ollesch, G., A. Kaunzinger, D. Juchelka, M. Schubert-Zsilavecz, and U. Ermler, 1999. Phospholipid bound to the flavohemoprotein from Alcaligenes europhus. Eur. J. Biochem. 262:396-405.
45. Ouellet, H., Y. Ouellet, C. Richard, M. Labarre, B. Wittenberg, J. Wittenberg, and M. Guertin. 2002. Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide. Proc. Natl. Acad. Sci. USA 99:5902-5907.
46. Pathania, R., N. K. Navani, A. M. Gardner, P. R. Gardner, and K. L. Dikshit. 2002. Nitric oxide scavenging and detoxification by the Mycobacterium tuberculosis haemoglobin, HbN in Escherischia coli. Mol. Microbiol. 45:1303-1314.
47. Podust, L. M., T. L. Poulos, and M. R. Waterman. 2001. Crystal structure of cytochrome P450 14a-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. USA 98:3068-3073.
48. Schär, G., F. H. Kayser, and M. C. Dupont. 1976. Antimicrobial activity of econazole and miconazole in vitro and in experimental candidiasis and aspergillosis. Chemotherapy 22:211-220.
49. Schierholz, J. M., C. Fleck, J. Beuth, and G. Pulverer. 2000. The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. J. Antimicrob. Chemother. 46:45-50.
50. Shimokawa, O., and K. Nakayama. 1992. Increased sensitivity of Candida albicans cells accumulating 14α-methylated sterols to active oxygen: possible relevance to in vivo efficacies of azole antifungal agents. Antimicrob. Agents Chemother. 36:1626-1629.
51. Stevanin, T. M., R. K. Poole, E. A. G. Demoncheaux, and R. C. Read. 2002. Flavohemoglobin Hmp protects Salmonella enterica serovar Typhimurium from nitric oxide-related killing by human macrophages. Infect. Immun. 70:4399-4405.
52. Sud, I. J., and D. S. Feingold. 1982. Action of antifungal imidazoles on Staphylococcus aureus. Antimicrob. Agents Chemother. 22:470-474.
53. Sud, I. J., and D. S. Feingold. 1981. Heterogeneity of action mechanisms among antimycotic imidazoles. Antimicrob. Agents Chemother. 20:71-74.
54. Sun, Z., and Y. Zhang. 1999. Antituberculosis activity of certain antifungal and antihelmintic drugs. Tuber. Lung Dis. 79:319-320.
55. Ullmann, B. D., H. Myers, W. Chiranand, A. L. Lazzell, Q. Zhao, L. A. Vega, J. L. Lopez-Ribot, P. R. Gardner, and M. C. Gustin. 2004. An inducible defense mechanism against nitric oxide in Candida albicans. Eukaryot. Cell 3:715-723.
56. Vanden Bossche, H., F. Cornelissen, and J. Van Cutsem. 1982. Synergism of the antimicrobial agents miconazole and benzoylperoxide. Br. J. Dermatol. 107:343-348.
57. Van den Bossche, H., G. Willemsens, W. Cools, W. F. J. Lauwers, and L. Le Jeune. 1978. Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans. Chem. Biol. Interact. 21:59-78.
58. Vanden Bossche, H., M. Engelen, and F. Rochelte. 2003. Antifungal agents of use in animal health-chemical, biochemical and pharmacological aspects. J. Vet. Pharmacol. Ther. 26:5-29.
59. von Recklinghausen, G., C. Di Maio, and R. Ansorg. 1993. Activity of antibiotics and azole antimycotics against Helicobacter pylori. Zentralbl. Bakteriol. 280:279-285.
60. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
61. Yanisch-Perron, C., C. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.
62. Yoshida, Y. 1988. Cytochrome P450 of fungi: primary target for azole antifungal agents. Curr. Top. Med. Mycol. 2:388-418.
63. 14DM purified from Saccharomyces cerevisiae microsomes. Biochem. Pharmacol. 36:229-235.
64. Zumft, W. 1997. Cell biology and molecular basis of denitrification. Microbiol. Mol. Biol. Rev. 61:533-616.